Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ineffective decrease of serum cholesterol by simvastatin in a subgroup of hypercholesterolemic coronary patients.

Tatu A Miettinen1, Helena Gylling

  • 1Department of Medicine, Division of Internal Medicine, University of Helsinki, P.O. Box 340, FIN-00029 HUS, Helsinki, Finland. tatu.a.miettinen@helsinki.fi

Atherosclerosis
|July 18, 2002
PubMed
Summary

Poor responders to simvastatin treatment exhibit higher cholesterol absorption and lower synthesis. Baseline cholesterol levels inversely relate to synthesis markers only in good responders, indicating distinct cholesterol metabolism pathways.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High cholesterol absorption efficiency enhances proatherogenic properties of low-density lipoprotein particles.

Journal of internal medicine·2026
Same author

A genome-wide association meta-analysis of cholesterol synthesis intermediates identifies three associations for lanosterol.

EBioMedicine·2026
Same author

High cholesterol absorption efficiency increases the risk of the nonfatal and fatal atherosclerotic events.

Journal of lipid research·2026
Same author

High cholesterol absorption efficiency interferes with bile acid metabolism and cholesterol elimination from the body.

Journal of internal medicine·2025
Same author

Heart-healthy diets including phytostanol ester consumption to reduce the risk of atherosclerotic cardiovascular diseases. A clinical review.

Lipids in health and disease·2024
Same author

Inflammation, infection, and cardiovascular risk.

Lancet (London, England)·2024

Area of Science:

  • Biochemistry
  • Pharmacology
  • Clinical Medicine

Background:

  • Cholesterol metabolism involves synthesis and absorption pathways.
  • Individual responses to statin therapy vary significantly.
  • Understanding these variations is crucial for effective cholesterol management.

Purpose of the Study:

  • To investigate differences in cholesterol synthesis and absorption markers between good and poor responders to simvastatin.
  • To explore the relationship between baseline cholesterol levels, synthesis/absorption markers, and treatment response.
  • To evaluate the impact of simvastatin dosage on cholesterol metabolism markers.

Main Methods:

  • Serum cholesterol, synthesis markers (lathosterol/cholesterol ratio), and absorption markers (campesterol/cholesterol ratio) were measured.

Related Experiment Videos

  • Data collected at baseline, 6 weeks, and 1 year from Finnish participants in the Scandinavian Simvastatin Survival Study.
  • Comparison between good responders (GR; 20 mg simvastatin) and poor responders (PR; 20 mg increased to 40 mg).

    • Main Results:

    • Poor responders had higher baseline cholesterol and absorption markers, and lower synthesis markers compared to good responders.
    • Precursor sterol ratios negatively correlated with baseline cholesterol in good responders only.
    • Simvastatin (20 mg) reduced cholesterol and synthesis markers more consistently in good responders; dose increase to 40 mg showed limited additional benefit in poor responders.

    Conclusions:

    • Patients requiring higher statin doses for cholesterol normalization exhibit high cholesterol absorption and low synthesis.
    • Baseline cholesterol levels are inversely related to synthesis markers primarily in good responders.
    • Statin effectiveness in altering cholesterol synthesis markers differs between good and poor responders, with larger doses showing less impact on synthesis in poor responders.